Based on the results of a prospective multicenter study, Gal-3 overexpression is now considered as a sensitive marker of thyroid malignancy and it is currently used in the preoperative diagnosis of thyroid cancer [20]. Here, LGALS3 is linked to thyroid gland carcinoma.